CHEK2 and myeloid leukemia: We also observe that, on a population level, LoF CHEK2 variants associate with hematopoietic abnormalities and myeloid leukemias; although CHEK2 was below the conventional 5e−8 threshold for GWAS analysis, HMs are underrepresented in the UKBB, limiting sensitivity in this context.